Ozempic Generic: Is There One in 2026? Patents, Canada, and What's Real

Search "Ozempic generic" and half the results sell you something that is not a generic. So let's be blunt up front.

Direct answer: No. There is no FDA-approved generic Ozempic in the United States in 2026, and there won't be one for years. Novo Nordisk's core composition-of-matter patent on semaglutide has been extended to December 2031, and analysts who track these things project a practical US generic launch around 2032. The drug's actual generic name is semaglutide — that's the molecule inside every Ozempic pen. Canada approved a real generic in 2026, but importing it into the US is illegal, and the cheap "compounded semaglutide" you see advertised is not a generic either. Below is the honest map of patents, the Canada situation, and the routes that actually lower your cost today.

The quick-answer matrix

"Generic name" is the query people actually mean

A big slice of "generic Ozempic" searches are really asking one thing: what's the chemical name? The answer is semaglutide. Ozempic is the brand name; semaglutide is the active ingredient — a GLP-1 receptor agonist injected once weekly. Wegovy and Rybelsus are also semaglutide, just different doses and labels. So when a clinician says "semaglutide," they mean the same molecule as Ozempic. Knowing this matters, because some marketing leans on the word "generic" to describe products that share the name semaglutide but skip FDA approval entirely.

Why there's no US generic: the patent wall

Ozempic is shielded by a stack of patents. The one that matters most is the compound patent covering semaglutide itself, which was extended to compensate for time lost during FDA review.

In 2023, a challenge by Mylan against the '343 patent failed at the patent office — a quiet but decisive moment that kept the December 2031 wall standing. In fall 2024, Novo Nordisk settled patent litigation with several generic makers, including Mylan, Dr. Reddy's, Apotex, and Sun Pharmaceuticals. The settlement terms are confidential, so the exact licensed entry date is unknown, but Markman Advisors' read of the chart is that generic Ozempic is likely to enter around 2032. In April 2026, Apotex won the first tentative FDA approval for a generic semaglutide injection — the agency agreed the product is sound, but it cannot be sold until the patents clear.

The Canada twist: a real generic exists, but you can't import it

Here's the part that confuses people. In April 2026, Canada became the first G7 country to approve a generic semaglutide. Apotex launched Apo-Semaglutide Injection — a true generic equivalent of Ozempic, with both 2 mg and 4 mg pens — and began shipping it on May 20, 2026. A Dr. Reddy's version followed. Canadian generics typically land at least 50% below brand, and Apotex's product came in around one-third of brand-Ozempic's price.

Why Canada and not the US? Novo Nordisk missed a patent maintenance fee payment in Canada, and under Canadian law a lapsed patent can't be revived. That opened the door years early. In the US, the patents are intact through ~2032.

Can you just order the Canadian generic? No. Personal importation of prescription drugs is generally a federal violation, and Ozempic is not covered by the FDA's narrow carve-outs. Canadian pharmacies are also only allowed to fill prescriptions written by a Canadian-licensed practitioner, so a US script won't work. Beyond the legality, the cross-border GLP-1 market is a known target for counterfeits.

Compounded semaglutide is not a generic — and the rules just tightened

During the 2022-2024 shortage, pharmacies legally compounded semaglutide. That window is closing. The FDA declared the semaglutide shortage resolved in February 2025, which ended the broad 503A compounding exception. Then, on April 30, 2026, the FDA proposed removing semaglutide (along with tirzepatide and liraglutide) from the 503B outsourcing-facility bulks list entirely, with a public comment period open through June 29, 2026. The agency's logic: when an FDA-approved drug is available, there's no clinical need to compound it from bulk.

Compounded semaglutide was never a generic. A generic must be FDA-approved and proven bioequivalent to the brand. Compounded product is neither — and the FDA logged hundreds of adverse-event reports tied to compounded GLP-1s. That said, doctor-supervised compounding through a licensed US pharmacy remains a legitimate, regulated route for now, which is where the value below comes in.

Want the generic price without the wait? Yücca telehealth — online evaluation, doctor-prescribed compounded Semaglutide+ or Tirzepatide+ filled by a licensed US pharmacy, from $146/month. (Partner link: we may earn a commission, at no extra cost to you.)

What to actually do until 2032

You can't buy a generic, but you can lower the price. These are the real routes.

For the full breakdown, see our Ozempic coupon guide and our roundup of the cheapest GLP-1 options. Curious how the molecule itself goes off-patent? Read the generic semaglutide timeline. If your goal is weight loss specifically, the Wegovy generic page covers the $149 oral pill route, and the Rybelsus generic page covers the oral-tablet patents.

Frequently asked questions

What is the generic name for Ozempic? Semaglutide. It's the active ingredient in Ozempic, Wegovy, and Rybelsus — the brand and dose differ, the molecule doesn't.

Is there a generic Ozempic for weight loss? No FDA-approved generic exists for any use. Ozempic itself is approved for type 2 diabetes; weight loss is an off-label effect. For a weight-loss label at a lower cash price, the oral Wegovy pill is the closest "generic-price" option.

Why does Canada have generic Ozempic but the US doesn't? Novo Nordisk let a patent lapse in Canada by missing a maintenance fee, and a lapsed Canadian patent can't be restored. US patents remain enforceable until roughly 2032.

Can I buy generic Ozempic from Canada online? Not legally. Personal importation of Ozempic into the US isn't permitted, Canadian pharmacies require a Canadian prescriber, and counterfeit risk is high.

Is compounded semaglutide the same as generic Ozempic? No. Compounded semaglutide isn't FDA-approved or bioequivalence-tested, and the FDA is moving to end bulk compounding now that the shortage is over.

When will generic Ozempic be available in the US? The earliest realistic window is around 2032, tied to the December 2031 expiration of the core semaglutide patent.

Last reviewed: June 13, 2026

Sources

• What is the patent landscape for Novo Nordisk's semaglutide products? — Markman Advisors
• Apotex Wins First Tentative FDA Approval for Generic Ozempic Semaglutide Injection — Prism News
• Generic semaglutide to hit Canadian pharmacies this week at lower cost — Global News
• Novo Nordisk missed a patent deadline in Canada, opening the door to generic GLP-1s — eMarketer
• FDA Moves to Permanently Close the Door on Compounded GLP-1s — Pharmacy Times
• Canadian pharmacy Ozempic: Cost, availability & more — SingleCare